Tarafenacin D-tartrate (SVT-40776 D-tartrate) is a potent and selective M3 muscarinic receptor antagonist. It is utilized in preclinical research to investigate overactive bladder and airway disorders, with studies demonstrating its functional effects in both in vitro and in vivo experimental models.